SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2019)

Cited 0|Views9
No score
Abstract
Treatment of septic shock has become standardized nationwide. Patients who fail adequate fluid resuscitation require urgent treatment with vasopressors. Only recently has physician's choice of vasopressor expanded to incorporate synthetic Angiotensin II (SA2). A 33-year-old male was transferred for
More
Translated text
Key words
angiotensin,septic myocarditis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined